Suppression by gabapentin of pain-related mechano-responses in mice given orthotopic tumor inoculation

Biological and Pharmaceutical Bulletin

Volumn 26, Issue 4, 2003, Pages 550-552

  Kuraishi, Yasushi ^a   Iida, Yuko ^a   Zhang, Hong Wei ^a   Uehara, Saori ^a   Nojima, Hiroshi ^a   Murata, Jun ^a   Saiki, Ikuo ^a   Takahata, Hiroki ^b   Ouchi, Hidekazu ^b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Acute tolerance; Analgesia; Analgesic adjuvants; Cancer pain; Gabapentin; Morphine

Indexed keywords

BACLOFEN; CLONIDINE; DICLOFENAC; GABAPENTIN; MEXILETINE; N(G) NITROARGININE METHYL ESTER; SURAMIN; 4 AMINOBUTYRIC ACID; ACETIC ACID DERIVATIVE; AMINE; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY POSTURE; CANCER PAIN; HYPERALGESIA; INHIBITION KINETICS; INOCULATION; MALE; MECHANORECEPTOR; MELANOMA; MOUSE; NONHUMAN; ANIMAL; C57BL MOUSE; DRUG EFFECT; DRUG SCREENING; MECHANOTRANSDUCTION; METHODOLOGY; PAIN; PAIN ASSESSMENT; PHYSIOLOGY; STIMULATION;

ACETIC ACIDS; AMINES; ANIMALS; CYCLOHEXANECARBOXYLIC ACIDS; GAMMA-AMINOBUTYRIC ACID; HYPERALGESIA; MALE; MECHANORECEPTORS; MECHANOTRANSDUCTION, CELLULAR; MELANOMA; MICE; MICE, INBRED C57BL; PAIN; PAIN MEASUREMENT; PHYSICAL STIMULATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0642347794     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.26.550     Document Type: Article

References (19)

1. Levy M. H., N. Engl J Med., 335, 1124-1132 (1996).
2. Sasamura T., Nakamura S., Iida Y., Fuji H., Murata J., Saiki I., Nojima H., Kuraishi Y., Eur. J. Pharmacol., 441, 185-191 (2002).
3. Zaang H.-W., Iida Y., Andoh , Nojima H., Murata J., Saiki I., Kuraishi Y., J. Pharmacol. Sci., 91, 167-170 (2003).
4. Takasaki I., Andoh T., Shiraki K., Kuraishi Y., Pain, 86, 95-101 (2000).
5. Zhang H W., Sasamara T., Iida Y., Nojima H., Murata J., Saiki I., Kuraishi Y., Pain Res., 16, 43-49 (2001).
6. Field M. J., McCleary S., Hughes J., Singh L., Pain, 80, 391-398 (1999).
7. Takasaki I., Andoh T., Nitta M., Takahata H., Nemoto H., Shiraki K., Nojima H., Kuraishi Y., Jpn. J. Pharmacol., 83, 319-326 (2000).
8. Takasaki I., Sasaki A., Andoh T., Nojima H., Shiraki K., Kuraishi Y., Anesthesiology, 96, 1168-1174 (2002).
9. Takasaki I., Andoh T., Nojima H., Shiraki K., Kuraishi Y., J Pharmacol. Exp Ther., 296, 270-275 (2001).
10. Rosenberg J. M., Harrell C., Ristic H., Werner R. A., de Rosayro A. M., Clin. J. Pain, 13, 251-255 (1997).
11. Rowbotham M., Harden N., Stacey B., Bernstein P., Magnus-Miller L., JAMA, 280, 1837-1842 (1998).
12. Caraceni A., Zecca E., Martini C., De Conno F., J. Pain Symptom. Manage, 17, 441-445 (1999).
13. Gee N. S., Brown J. P., Dissanayake V. U. K., Offord J., Thurlow R., Woodruff G. N., J. Biol. Chem., 271, 5768-5776 (1996)
14. Shimoyama M., Shimoyama N., Hori Y., Pain, 85, 405-414 (2000).
15. Jun J. H., Yaksh T. L., Anesth. Analg., 86, 348-354 (1998).
16. Turner T. J., Adams M E., Dunlap K., Proc. Natl Acad. Sci U.S.A., 90, 9518-9522 (1993).
17. Malmberg A. B., Yaksh T. L., J. Neurosci., 14, 4882-4890 (1994).
18. Handy R. L., Moore P. K., Neuropharmacology. 37, 37-43 (1998).
19. Pauk S. K., Chung K., Chung J. M., Pain, 87, 171-179 (2000).